Invest in Simpli-Fi Automation, Inc.

Develop AI-powered medical diagnostic and human performance technologies using Breath Biomarkers

EARLY BIRD TERMS: $98,250 LEFT

$1,750

of a $50,000 goal
INVESTMENT TERMS
Future Equity
 $8M  $7.2M valuation cap
Early Bird Bonus: The first $100K of investments will be in a SAFE with a $7.2M valuation cap and 20% discount
$250, $500, $1K, $10K

Highlights

1
We have a commercialization license to develop the NASA Electronic Nose for human medical use.
2
NASA e-Nose technology has been clinically proven to detect Covid-19 using breath. (Standford/NASA)
3
We are currently manufacturing our commercial beta prototype for pre-clinical validation.
4
Our technology has been selected for the Defense Innovation Unit Military Health Readiness Platform.

Featured Investors

Our Team


Healthcare Ai meets the sense of Smell















Sources: Arizton, MarketsandMarkets, Insights Partner








Downloads

Overview